[Surgical strategies and efficacy analysis for aortic dissection complicating intractable mesenteric artery ischemia]

Zhonghua Wai Ke Za Zhi. 2024 Mar 1;62(3):235-241. doi: 10.3760/cma.j.cn112139-20230926-00141.
[Article in Chinese]

Abstract

Objective: To explore the surgical strategies and clinical efficacy for aortic dissection combined with refractory superior mesenteric artery (SMA) ischemia. Methods: This is a retrospective case series study. Clinical data of 24 patients with aortic dissection and refractory SMA ischemia admitted to the Department of Vascular Surgery, Zhongshan Hospital, Fudan University from August 2010 to August 2020 were retrospectively collected. Of the 24 patients, 21 were males and 3 were females, with an age of (50.3±9.9) years (range: 44 to 72 years).Among them, 9 cases were Stanford type A aortic dissection, and 15 cases were type B. All patients underwent CT angiography upon admission, and based on imaging characteristics, they were classified into three types. Type Ⅰ: severe stenosis/occlusion of the SMA true lumen only; Type Ⅱ: stenosis of the true lumens in the descending aorta and SMA (isolated type); Type Ⅲ: stenosis of the true lumens in the thoracoabdominal aorta and SMA (continuation type). Surgical procedures, complications, mortality, and reintervention rates were recorded. Results: Among the 24 patients, 17 (70.8%) were classified as Type Ⅰ, 4 (16.7%) as Type Ⅱ, and 3 (12.5%) as Type Ⅲ. Fourteen cases of Type Ⅰ underwent thoracic endovascular aortic repair combined with SMA stent implantation. Additionally, 3 Type Ⅰ and 1 Type Ⅱ patients underwent only SMA reconstruction (with one case of chronic TAAD treated with iliac artery-SMA bypass surgery). Moreover, 3 Type Ⅱ and 3 Type Ⅲ patients underwent descending aorta combined with SMA stent implantation. There were 5 patients (20.8%) who underwent small bowel resection, either in the same sitting or in a staged procedure. During hospitalization, 4 patients died, resulting in a mortality rate of 16.7%. Among these cases, two patients succumbed to severe intestinal ischemia resulting in multiple organ dysfunction syndrome. The follow-up duration was (46±9) months (range: 13 to 72 months). During the follow-up, 2 patients died, unrelated to intestinal ischemia. The 5-year freedom from reintervention survival rate was 86.1%, and the 5-year cumulative survival rate was 82.6%. Conclusions: Patients with aortic dissection and refractory SMA ischemia have a high perioperative mortality. However, implementing appropriate surgical strategies according to different clinical scenarios can reduce mortality and alleviate intestinal ischemia.

目的: 探讨主动脉夹层合并难治性肠系膜上动脉(SMA)缺血的手术策略与临床疗效。 方法: 本研究为回顾性病例系列研究。收集2010年8月至2020年8月复旦大学附属中山医院血管外科收治的24例主动脉夹层合并难治性SMA缺血患者的临床资料。男性21例,女性3例,年龄(50.3±9.9)岁(范围:44~72岁)。A型主动脉夹层(TAAD)9例,B型主动脉夹层(TBAD)15例。患者入院后均行CT血管造影检查,根据影像学特征将患者分为3型:Ⅰ型,仅SMA真腔重度狭窄或闭塞;Ⅱ型,降主动脉合并SMA真腔狭窄(分离型);Ⅲ型,SMA上段胸腹主动脉合并SMA真腔狭窄(延续型)。根据影像学分型不同采用相应的SMA腔内治疗方法。记录患者的影像学分型、手术情况及并发症情况;采用Kaplan-Meier法绘制生存曲线,并计算生存率及再干预率。 结果: 24例患者中,Ⅰ型17例(70.8%),Ⅱ型4例(16.7%),Ⅲ型3例(12.5%)。14例Ⅰ型患者采用TEVAR加SMA支架植入术治疗;3例Ⅰ型及1例Ⅱ型患者仅行SMA重建(1例慢性TAAD患者行髂动脉-SMA旁路术治疗);3例Ⅱ型及3例Ⅲ型患者采用降主动脉联合SMA裸支架植入术;同期或二期行部分小肠切除术5例(20.8%)。住院期间4例患者死亡,病死率为16.7%,其中2例患者死于严重肠缺血导致的多器官功能衰竭。术后随访(46±9)个月(范围:13~72个月),期间2例患者死亡,均与肠缺血无关。患者的5年期免于再干预生存率为86.1%,5年期累积生存率为82.6%。 结论: 主动脉夹层合并难治性SMA缺血患者围术期病死率高,风险大,针对不同临床场景采用相应的手术策略可缓解肠缺血,改善患者预后。.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aortic Aneurysm, Thoracic* / surgery
  • Aortic Dissection* / surgery
  • Blood Vessel Prosthesis Implantation* / adverse effects
  • Constriction, Pathologic / complications
  • Endovascular Procedures* / adverse effects
  • Female
  • Humans
  • Ischemia / surgery
  • Male
  • Mesenteric Artery, Superior / surgery
  • Mesenteric Ischemia* / etiology
  • Middle Aged
  • Retrospective Studies
  • Stents / adverse effects
  • Treatment Outcome